Melanocytic nevus epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (9 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Melanocytic nevus}} | {{Melanocytic nevus}} | ||
{{CMG}}; {{AE}} {{Qurrat}} | |||
==Overview== | ==Overview== | ||
| Line 8: | Line 9: | ||
==Epidemiology and demographics== | ==Epidemiology and demographics== | ||
=== Prevalence === | |||
*The prevalence of congenital melanocytic nevi (CMN) in newborns is between 0.2 and 6% worldwide.<ref name="pmid17377384">{{cite journal |vauthors=Ingordo V, Gentile C, Iannazzone SS, Cusano F, Naldi L |title=Congenital melanocytic nevus: an epidemiologic study in Italy |journal=Dermatology (Basel) |volume=214 |issue=3 |pages=227–30 |date=2007 |pmid=17377384 |doi=10.1159/000099587 |url=}}</ref> | |||
*The number of acquired moles among white children depends on the geographical area and sun exposure and its intensity.<ref name="pmid15897379">{{cite journal |vauthors=Valiukeviciene S, Miseviciene I, Gollnick H |title=The prevalence of common acquired melanocytic nevi and the relationship with skin type characteristics and sun exposure among children in Lithuania |journal=Arch Dermatol |volume=141 |issue=5 |pages=579–86 |date=May 2005 |pmid=15897379 |doi=10.1001/archderm.141.5.579 |url=}}</ref> | |||
=== Age === | |||
*According to the American Academy of Dermatology, the majority of moles appear during the first two decades of a person’s life. <ref name="pmid7554507">{{cite journal |vauthors=Gallagher RP, McLean DI |title=The epidemiology of acquired melanocytic nevi. A brief review |journal=Dermatol Clin |volume=13 |issue=3 |pages=595–603 |date=July 1995 |pmid=7554507 |doi= |url=}}</ref> | |||
=== Race === | |||
* | |||
*Darker skin shades tend to have fewer moles. | |||
=== Gender === | |||
* Melanocytic nevi affect men and women equally. | |||
<br /> | |||
==References== | ==References== | ||
| Line 19: | Line 37: | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Plastic surgery]] | [[Category:Plastic surgery]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Dermatology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 19:42, 12 September 2019
|
Melanocytic nevus Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Melanocytic nevus epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Melanocytic nevus epidemiology and demographics |
|
Risk calculators and risk factors for Melanocytic nevus epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2]
Overview
Darker skin shades tend to have fewer moles compared to fair complexion.
Epidemiology and demographics
Prevalence
- The prevalence of congenital melanocytic nevi (CMN) in newborns is between 0.2 and 6% worldwide.[1]
- The number of acquired moles among white children depends on the geographical area and sun exposure and its intensity.[2]
Age
- According to the American Academy of Dermatology, the majority of moles appear during the first two decades of a person’s life. [3]
Race
- Darker skin shades tend to have fewer moles.
Gender
- Melanocytic nevi affect men and women equally.
References
- ↑ Ingordo V, Gentile C, Iannazzone SS, Cusano F, Naldi L (2007). "Congenital melanocytic nevus: an epidemiologic study in Italy". Dermatology (Basel). 214 (3): 227–30. doi:10.1159/000099587. PMID 17377384.
- ↑ Valiukeviciene S, Miseviciene I, Gollnick H (May 2005). "The prevalence of common acquired melanocytic nevi and the relationship with skin type characteristics and sun exposure among children in Lithuania". Arch Dermatol. 141 (5): 579–86. doi:10.1001/archderm.141.5.579. PMID 15897379.
- ↑ Gallagher RP, McLean DI (July 1995). "The epidemiology of acquired melanocytic nevi. A brief review". Dermatol Clin. 13 (3): 595–603. PMID 7554507.